JNJ

238.68

-0.55%↓

UNH

274.9

-0.55%↓

TMO

546.83

+0.89%↑

ABT

111.08

+0.23%↑

ISRG

492.83

+1.14%↑

JNJ

238.68

-0.55%↓

UNH

274.9

-0.55%↓

TMO

546.83

+0.89%↑

ABT

111.08

+0.23%↑

ISRG

492.83

+1.14%↑

JNJ

238.68

-0.55%↓

UNH

274.9

-0.55%↓

TMO

546.83

+0.89%↑

ABT

111.08

+0.23%↑

ISRG

492.83

+1.14%↑

JNJ

238.68

-0.55%↓

UNH

274.9

-0.55%↓

TMO

546.83

+0.89%↑

ABT

111.08

+0.23%↑

ISRG

492.83

+1.14%↑

JNJ

238.68

-0.55%↓

UNH

274.9

-0.55%↓

TMO

546.83

+0.89%↑

ABT

111.08

+0.23%↑

ISRG

492.83

+1.14%↑

Search

Premier Inc

Закрыт

СекторЗдравоохранение

0

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

Макс.

Ключевые показатели

By Trading Economics

Доход

-993K

18M

Продажи

-23M

240M

P/E

Средняя по отрасли

166.235

84.243

Дивидендная доходность

2.97

Рентабельность продаж

7.324

Сотрудники

2,700

EBITDA

-7.9M

53M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

-0.04% downside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

2.97%

2.28%

Рыночная статистика

By TradingEconomics

Рыночная капитализация

5.8M

2.3B

Предыдущая цена открытия

0

Предыдущая цена закрытия

0

Новостные настроения

By Acuity

50%

50%

139 / 352 Рейтинг в Healthcare

Техническая оценка

By Trading Central

Уверенность

Weak Bullish Evidence

Premier Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

9 февр. 2026 г., 17:25 UTC

Приобретения, слияния, поглощения

Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion -- Update

9 февр. 2026 г., 23:46 UTC

Обсуждения рынка

Nikkei May Rise on Hopes for Domestic Policy Measures -- Market Talk

9 февр. 2026 г., 23:43 UTC

Обсуждения рынка

Gold Falls on Possible Technical Correction -- Market Talk

9 февр. 2026 г., 23:14 UTC

Обсуждения рынка

WiseTech's Bull Reckons AI-Driven Selloff Is Overdone -- Market Talk

9 февр. 2026 г., 22:29 UTC

Обсуждения рынка

Australian Coking Coal Price Seen Falling Once Supply Disruptions Ease -- Market Talk

9 февр. 2026 г., 22:19 UTC

Обсуждения рынка

Pro Medicus's Business Case Made More Compelling by AI Adoption -- Market Talk

9 февр. 2026 г., 22:08 UTC

Обсуждения рынка

Minerals 260 Bull Bets on Production Scale, Takeover Appeal -- Market Talk

9 февр. 2026 г., 22:01 UTC

Отчет

Friedman Industries Sees 4Q Sales Volume to Generally Consistent With 3Q, With Sequential Improvement in Sales Margins

9 февр. 2026 г., 21:59 UTC

Отчет

Friedman Industries: Hedging Activities Continued to Perform as Anticipated by Mitigating Impact of Commodity Price Volatility

9 февр. 2026 г., 21:59 UTC

Отчет

Friedman Industries: Average Selling Prices Began to Improve as Quarter Progressed

9 февр. 2026 г., 21:58 UTC

Отчет

Friedman Industries 3Q Sales $168M >FRD

9 февр. 2026 г., 21:50 UTC

Обсуждения рынка
Приобретения, слияния, поглощения

Financial Services Roundup: Market Talk

9 февр. 2026 г., 21:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

9 февр. 2026 г., 21:48 UTC

Отчет

Friedman Industries 3Q EPS 43c >FRD

9 февр. 2026 г., 21:17 UTC

Отчет

Kyndryl Stock Drops 55%. It's So Much Worse Than an Earnings Miss. -- Barrons.com

9 февр. 2026 г., 21:13 UTC

Обсуждения рынка

U.S. Ethanol Crush Margins Near Break-Even -- Market Talk

9 февр. 2026 г., 21:04 UTC

Отчет

Retail Sales Data Should Confirm a Robust Holiday Season -- Barrons.com

9 февр. 2026 г., 20:30 UTC

Обсуждения рынка

Oil Futures Gain As U.S.-Iran Risk Premium Holds -- Market Talk

9 февр. 2026 г., 20:02 UTC

Обсуждения рынка

U.S. Natural Gas Falls on Warmer Weather Outlook -- Market Talk

9 февр. 2026 г., 19:42 UTC

Обсуждения рынка

Japan's Yield Curve Expected to Flatten -- Market Talk

9 февр. 2026 г., 19:31 UTC

Обсуждения рынка

Nike Seen Regaining Relevance With Consumers -- Market Talk

9 февр. 2026 г., 19:27 UTC

Обсуждения рынка

Gold Climbs Back Over $5,000/oz -- Market Talk

9 февр. 2026 г., 19:05 UTC

Обсуждения рынка

Nike Returns to List of Hottest Brands -- Market Talk

9 февр. 2026 г., 18:19 UTC

Обсуждения рынка

Lower Dollar Doesn't Translate to Boost in Grains -- Market Talk

9 февр. 2026 г., 17:41 UTC

Отчет
Приобретения, слияния, поглощения

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, AppLovin, Monday.com, Valaris, and More -- Barrons.com

9 февр. 2026 г., 17:31 UTC

Отчет
Приобретения, слияния, поглощения

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, Monday.com, Valaris, Cleveland-Cliffs, and More -- Barrons.com

9 февр. 2026 г., 17:20 UTC

Обсуждения рынка
Приобретения, слияния, поглощения

Financial Services Roundup: Market Talk

9 февр. 2026 г., 17:20 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

9 февр. 2026 г., 17:17 UTC

Обсуждения рынка

Century Aluminum Announces Next Steps of Okla. Project -- Market Talk

9 февр. 2026 г., 17:16 UTC

Отчет

Kyndryl Stock Drops 56%. It's So Much Worse Than an Earnings Miss. -- Barrons.com

Сравнение c конкурентами

Изменение цены

Premier Inc Прогноз

Целевая цена

By TipRanks

-0.04% падение

Прогноз на 12 месяцев

Средняя 28.25 USD  -0.04%

Максимум 28.25 USD

Минимум 28.25 USD

Основано на мнении 5 аналитиков Wall Street, спрогнозировавших целевые цены для Premier Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

5 ratings

0

Покупка

5

Удержание

0

Продажа

Техническая оценка

By Trading Central

20.38 / N/AПоддержка и Сопротивление

Краткосрочная

Weak Bullish Evidence

Среднесрочная

Weak Bearish Evidence

Долгосрочная

Strong Bullish Evidence

Настроения

By Acuity

144 / 352Рейтинг в Здравоохранение

Новостные настроения

Neutral

Волатильность

Ниже среднего

Объем новостей (RCV)

Средняя

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Premier Inc

Premier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions. This segment also provides the ASCENDrive programs for members to receive group purchasing programs, tiers, and prices; SURPASS Performance Group services for coordinate purchasing decisions, review utilization and achieve and maintain standardization across member's facilities; SaaS informatics products for the purchase additional elements; supply chain co-management services; purchased services contracts; direct sourcing solutions; and supply chain resiliency programs. The Performance Services segment provides technology and services platform with offerings that help optimize performance in three main areas, including clinical intelligence, margin improvement, and value-based care under the PINC AI brand; third party administrator services and management of health benefit programs under the Contigo Health brand; and digital invoicing and payables services that offers financial support services to healthcare product suppliers and service providers under the Remitra brand. The company was incorporated in 2013 and is headquartered in Charlotte, North Carolina.
help-icon Live chat